203 related articles for article (PubMed ID: 12065510)
1. Improved tuberculosis DNA vaccines by formulation in cationic lipids.
D'Souza S; Rosseels V; Denis O; Tanghe A; De Smet N; Jurion F; Palfliet K; Castiglioni N; Vanonckelen A; Wheeler C; Huygen K
Infect Immun; 2002 Jul; 70(7):3681-8. PubMed ID: 12065510
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment.
Tanghe A; Denis O; Lambrecht B; Motte V; van den Berg T; Huygen K
Infect Immun; 2000 Jul; 68(7):3854-60. PubMed ID: 10858194
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors.
Tanghe A; Lefèvre P; Denis O; D'Souza S; Braibant M; Lozes E; Singh M; Montgomery D; Content J; Huygen K
J Immunol; 1999 Jan; 162(2):1113-9. PubMed ID: 9916741
[TBL] [Abstract][Full Text] [Related]
4. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3.
Romano M; Roupie V; Wang XM; Denis O; Jurion F; Adnet PY; Laali R; Huygen K
Immunology; 2006 Jul; 118(3):321-32. PubMed ID: 16827893
[TBL] [Abstract][Full Text] [Related]
6. Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis.
D'Souza S; Rosseels V; Romano M; Tanghe A; Denis O; Jurion F; Castiglione N; Vanonckelen A; Palfliet K; Huygen K
Infect Immun; 2003 Jan; 71(1):483-93. PubMed ID: 12496199
[TBL] [Abstract][Full Text] [Related]
7. Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.
Tanghe A; D'Souza S; Rosseels V; Denis O; Ottenhoff TH; Dalemans W; Wheeler C; Huygen K
Infect Immun; 2001 May; 69(5):3041-7. PubMed ID: 11292722
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.
Lozes E; Huygen K; Content J; Denis O; Montgomery DL; Yawman AM; Vandenbussche P; Van Vooren JP; Drowart A; Ulmer JB; Liu MA
Vaccine; 1997 Jun; 15(8):830-3. PubMed ID: 9234526
[TBL] [Abstract][Full Text] [Related]
9. Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis.
Cai H; Tian X; Hu XD; Zhuang YH; Zhu YX
DNA Cell Biol; 2004 Jul; 23(7):450-6. PubMed ID: 15294094
[TBL] [Abstract][Full Text] [Related]
10. Induction of in vivo functional Db-restricted cytolytic T cell activity against a putative phosphate transport receptor of Mycobacterium tuberculosis.
Romano M; Denis O; D'Souza S; Wang XM; Ottenhoff TH; Brulet JM; Huygen K
J Immunol; 2004 Jun; 172(11):6913-21. PubMed ID: 15153510
[TBL] [Abstract][Full Text] [Related]
11. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis.
Kamath AT; Feng CG; Macdonald M; Briscoe H; Britton WJ
Infect Immun; 1999 Apr; 67(4):1702-7. PubMed ID: 10085007
[TBL] [Abstract][Full Text] [Related]
12. T-bet acts as a powerful adjuvant in Ag85B DNA‑based vaccination against tuberculosis.
Hu D; Wu J; Zhang R; Chen L
Mol Med Rep; 2012 Jul; 6(1):139-44. PubMed ID: 22552442
[TBL] [Abstract][Full Text] [Related]
13. Immune responses induced by heterologous boosting of recombinant bacillus Calmette-Guerin with Ag85B-ESAT6 fusion protein in levamisole-based adjuvant.
You Q; Wu Y; Jiang D; Wu Y; Wang C; Wei W; Yu X; Zhang X; Kong W; Jiang C
Immunol Invest; 2012; 41(4):412-28. PubMed ID: 22360290
[TBL] [Abstract][Full Text] [Related]
14. Protection of mice with a divalent tuberculosis DNA vaccine encoding antigens Ag85B and MPT64.
Tian X; Cai H; Zhu YX
Acta Biochim Biophys Sin (Shanghai); 2004 Apr; 36(4):269-76. PubMed ID: 15253152
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system.
Meerak J; Wanichwecharungruang SP; Palaga T
Vaccine; 2013 Jan; 31(5):784-90. PubMed ID: 23228812
[TBL] [Abstract][Full Text] [Related]
16. Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.
Dou J; Tang Q; Yu F; Yang H; Zhao F; Xu W; Wang J; Hu W; Hu K; Liou C; Feng He X; Wang Y
Immunobiology; 2010; 215(2):133-42. PubMed ID: 19450898
[TBL] [Abstract][Full Text] [Related]
17. Novel adjuvant for immunization against tuberculosis: DNA vaccine expressing Mycobacterium tuberculosis antigen 85A and interleukin-15 fusion product elicits strong immune responses in mice.
Sun L; Yuan Q; Xu T; Yao L; Feng J; Ma J; Wang L; Lv C; Wang D
Biotechnol Lett; 2017 Aug; 39(8):1159-1166. PubMed ID: 28470626
[TBL] [Abstract][Full Text] [Related]
18. Partial reconstitution of the CD4+-T-cell compartment in CD4 gene knockout mice restores responses to tuberculosis DNA vaccines.
D'Souza S; Romano M; Korf J; Wang XM; Adnet PY; Huygen K
Infect Immun; 2006 May; 74(5):2751-9. PubMed ID: 16622212
[TBL] [Abstract][Full Text] [Related]
19. Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85A.
Gartner T; Baeten M; Otieno S; Revets H; De Baetselier P; Huygen K
Immunol Lett; 2007 Jul; 111(1):26-35. PubMed ID: 17570535
[TBL] [Abstract][Full Text] [Related]
20. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model.
Fan X; Gao Q; Fu R
Microbiol Res; 2009; 164(4):374-82. PubMed ID: 17764918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
